Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.23 USD | -2.42% |
|
-2.11% | +22.26% |
17/06 | Design Therapeutics, Inc. Elects Pratik Shah, Ph.D. as Class III Director | CI |
08/05 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.26% | 19Cr | |
+25.72% | 5.27TCr | |
+37.49% | 3.9TCr | |
-9.02% | 3.85TCr | |
+28.07% | 3.04TCr | |
-12.26% | 2.64TCr | |
+10.34% | 2.61TCr | |
+44.91% | 1.42TCr | |
+32.49% | 1.26TCr | |
-6.07% | 1.15TCr |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Wedbush Starts Design Therapeutics at Outperform With $21 Price Target